The therapeutic index of KIF18A inhibition in cancer patients with CIN tumors is still unknown, especially given its role in maintaining essential mitotic machinery and other potential phenotypic defects13. The gene discussed is KIF18A; the disease is cervical squamous intraepithelial neoplasia.